Literature DB >> 24548987

Warfarin pharmacogenetics: an illustration of the importance of studies in minority populations.

M A Perera1, L H Cavallari2, J A Johnson3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24548987      PMCID： PMC4131541          DOI： 10.1038/clpt.2013.209

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

1.  Polymorphism discovery in 51 chemotherapy pathway genes.

Authors:  Robert R Freimuth; Ming Xiao; Sharon Marsh; Matthew Minton; Nicholas Addleman; Derek J Van Booven; Howard L McLeod; Pui-Yan Kwok
Journal:  Hum Mol Genet       Date:  2005-10-20       Impact factor: 6.150

2.  Drift, admixture, and selection in human evolution: a study with DNA polymorphisms.

Authors:  A M Bowcock; J R Kidd; J L Mountain; J M Hebert; L Carotenuto; K K Kidd; L L Cavalli-Sforza
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

3.  Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups.

Authors:  Nita A Limdi; Mia Wadelius; Larisa Cavallari; Niclas Eriksson; Dana C Crawford; Ming-Ta M Lee; Chien-Hsiun Chen; Alison Motsinger-Reif; Hersh Sagreiya; Nianjun Liu; Alan H B Wu; Brian F Gage; Andrea Jorgensen; Munir Pirmohamed; Jae-Gook Shin; Guilherme Suarez-Kurtz; Stephen E Kimmel; Julie A Johnson; Teri E Klein; Michael J Wagner
Journal:  Blood       Date:  2010-03-04       Impact factor: 22.113

4.  Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.

Authors:  Danxin Wang; Huizi Chen; Kathryn M Momary; Larisa H Cavallari; Julie A Johnson; Wolfgang Sadée
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

5.  Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study.

Authors:  Minoli A Perera; Larisa H Cavallari; Nita A Limdi; Eric R Gamazon; Anuar Konkashbaev; Roxana Daneshjou; Anna Pluzhnikov; Dana C Crawford; Jelai Wang; Nianjun Liu; Nicholas Tatonetti; Stephane Bourgeois; Harumi Takahashi; Yukiko Bradford; Benjamin M Burkley; Robert J Desnick; Jonathan L Halperin; Sherief I Khalifa; Taimour Y Langaee; Steven A Lubitz; Edith A Nutescu; Matthew Oetjens; Mohamed H Shahin; Shitalben R Patel; Hersh Sagreiya; Matthew Tector; Karen E Weck; Mark J Rieder; Stuart A Scott; Alan H B Wu; James K Burmester; Mia Wadelius; Panos Deloukas; Michael J Wagner; Taisei Mushiroda; Michiaki Kubo; Dan M Roden; Nancy J Cox; Russ B Altman; Teri E Klein; Yusuke Nakamura; Julie A Johnson
Journal:  Lancet       Date:  2013-06-05       Impact factor: 79.321
  5 in total
  16 in total

1.  Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.

Authors:  A Owusu Obeng; T Kaszemacher; N S Abul-Husn; O Gottesman; A Vega; E Waite; K Myers; J Cho; E P Bottinger; S B Ellis; S A Scott
Journal:  Clin Pharmacol Ther       Date:  2016-08-18       Impact factor: 6.875

2.  Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.

Authors:  Elizabeth Abou Diwan; Ralph I Zeitoun; Lea Abou Haidar; Ingolf Cascorbi; Nathalie Khoueiry Zgheib
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

3.  If We Would Only Ask: How Henrietta Lacks Continues to Teach Us About Perceptions of Research and Genetic Research Among African Americans Today.

Authors:  Bridgette L Jones; Carrie A Vyhlidal; Andrea Bradley-Ewing; Ashley Sherman; Kathy Goggin
Journal:  J Racial Ethn Health Disparities       Date:  2016-09-23

4.  Quantitative Assessment of CYP2C9 Genetic Polymorphisms Effect on the Oral Clearance of S-Warfarin in Healthy Subjects.

Authors:  Chanan Shaul; Simcha Blotnick; Mordechai Muszkat; Meir Bialer; Yoseph Caraco
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 5.  Implementing Precision Medicine: The Ethical Challenges.

Authors:  Diane M Korngiebel; Kenneth E Thummel; Wylie Burke
Journal:  Trends Pharmacol Sci       Date:  2016-12-07       Impact factor: 14.819

6.  Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.

Authors:  Rui Nagai; Minami Ohara; Larisa H Cavallari; Katarzyna Drozda; Shitalben R Patel; Edith A Nutescu; Minoli A Perera; Wenndy Hernandez; Naoko Kaneko; Manabu Hibiya; Harumi Takahashi
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

7.  Integrating electronic health record genotype and phenotype datasets to transform patient care.

Authors:  D M Roden; J C Denny
Journal:  Clin Pharmacol Ther       Date:  2016-01-26       Impact factor: 6.875

8.  Genomics in research and health care with Aboriginal and Torres Strait Islander peoples.

Authors:  Rebekah McWhirter; Dianne Nicol; Julian Savulescu
Journal:  Monash Bioeth Rev       Date:  2015 Jun-Sep

9.  Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.

Authors:  Roxana Daneshjou; Eric R Gamazon; Ben Burkley; Larisa H Cavallari; Julie A Johnson; Teri E Klein; Nita Limdi; Sara Hillenmeyer; Bethany Percha; Konrad J Karczewski; Taimour Langaee; Shitalben R Patel; Carlos D Bustamante; Russ B Altman; Minoli A Perera
Journal:  Blood       Date:  2014-07-30       Impact factor: 22.113

Review 10.  Warfarin Pharmacogenomics in Diverse Populations.

Authors:  Justin B Kaye; Lauren E Schultz; Heidi E Steiner; Rick A Kittles; Larisa H Cavallari; Jason H Karnes
Journal:  Pharmacotherapy       Date:  2017-09-06       Impact factor: 4.705
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.